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ABSTRACT
Introduction: Hepatitis B is common in Brazil, although there are regional differences regarding the degree 
of endemicity, the most frequent forms of transmission and the presence of different evolutive stages of 
chronic disease. The present study aimed to determine the clinical, demographic and epidemiological 
characteristics of patients chronically infected with hepatitis B virus (HBV) residing in the Ribeirão 
Preto region, southeastern Brazil. Methods: A total of 529 medical records of individuals with HBV 
monoinfection were reviewed. Results: More than 60% of the subjects were males, with a mean age of 38 
years-old. The HBeAg-negative serological pattern was verified in 84.4% of the patients, among whom the 
risk of vertical/intrafamily transmission was 43.2% (p = 0.02). The consumption of alcohol in amounts 
exceeding 20g a day was observed in 21.3% of the subjects and was more frequent among men (33%) 
(p < 0.001). Among patients with cirrhosis, 54.1% were alcohol abusers (p = 0.04), all of them males. 
The presence of cirrhosis was more frequent in the HBeAg-positive group (24.4%) than in the HBeAg-
negative group (10.2%) (p < 0.001). Conclusions: High proportions of HBV-infected subjects with an 
HBeAg-negative pattern were observed, with a higher risk of vertical/intrafamily transmission. Alcohol 
abuse was associated with male subjects and with cirrhosis of the liver in this group. A tendency toward 
an increase in the number of HBeAg-negative cases was observed over time.
Keywords: Hepatitis B. Epidemiology. Transmission. Hepatitis B E antigens.
RESUMO
Introdução: No Brasil, a hepatite B é comum. No entanto, há diferenças regionais no que diz respeito ao 
grau de endemicidade, as formas de transmissão mais encontradas e a presença dos diferentes estágios 
evolutivos da doença crônica. O objetivo deste trabalho foi o de conhecer características clínicas, 
demográficas e epidemiológicas de pacientes cronicamente infectados pelo vírus da hepatite B (HBV), 
residentes na região de Ribeirão Preto, no sudeste do Brasil. Métodos: Foi realizada a análise retrospectiva 
de 529 prontuários de indivíduos com monoinfecção pelo HBV. Resultados: Mais de 60% eram 
masculinos, a média de idade foi de 38 anos. O padrão sorológico HBeAg negativo foi encontrado em 
84,4% dos pacientes, entre os quais o risco para transmissão vertical/intrafamiliar foi de 43,2% (p = 0,02). 
Verificou-se uso de álcool em quantidades maiores que 20g ao dia em 21,3% dos indivíduos, sendo mais 
frequente entre os homens (33%) (p < 0,001). Entre os pacientes com cirrose, 54,1% faziam uso abusivo 
de bebidas alcoólicas (p = 0,04), sendo todos estes do gênero masculino. A presença de cirrose foi maior 
no grupo HBeAg positivo (24,4%) que no grupo HBeAg negativo (10,2%) (p < 0,001). Conclusões: 
Observaram-se elevadas proporções de indivíduos com infecção pelo HBV com padrão sorológico HBeAg 
negativo, entre os quais houve maior risco para a transmissão vertical/intrafamiliar. O uso abusivo de 
álcool esteve associado a indivíduos do sexo masculino e, neste grupo, à cirrose hepática. Observou-se 
tendência ao aumento no número de casos HBeAg negativo ao longo do tempo.
Palavras-chaves: Hepatite B. Epidemiologia. Transmissão. Antígenos E da Hepatite B.
Hepatitis B is one of the most common infectious 
diseases worldwide. More than 2 billion people have 
had contact with hepatitis B virus (HBV) and about 
350 million people have the chronic form of infection1-3. 
The importance of chronic infection resides in the 
risk of developing serious forms of hepatic disease, 
such as cirrhosis, liver failure and hepatocellular 
carcinoma (HCC)1-3. Although most individuals 
do not develop complications during their lifetime, 
15 to 40% of persons with chronic HBV infection 
will present sequelae related to infection, with a 
10 to 20% estimate of progression to cirrhosis every 
5 years1-3. The relative risk of developing HCC among 
chronically HBV-infected individuals ranges from 
5.6 to 103.0 and the age of the individual at the time 
of infection is important in determining this risk1-4.
The incidence of hepatitis B, the patterns of 
transmission and the frequency of different stages in 
the natural history of chronic HBV infection varies 
widely throughout the world in different population 
subgroups1,3. In Brazil, studies conducted in capitals 
and major cities show data consistent with low or 
intermediate levels of endemicity5-10. The Amazon 
region, some areas in the State of Espirito Santo and 
the western areas of the States of Parana and Santa 
Catarina are distinguished from other Brazilian 
regions by the high prevalence of HBV infection7,11,12. 
In areas of low prevalence, transmission occurs more 
frequently among adolescents and adults, especially 
through sexual relations. In contrast, in areas of 
intermediate and high prevalence, data show higher 
rates of vertical and intrafamilial transmissions7,8,13-15. 
The frequency of the different phases involved in the 
natural history of chronic HBV infection has been 
poorly investigated in Brazil. Few studies include 
frequency analysis of HBeAg negative and HBeAg 
positive forms of the chronic infection16,17.
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RESULTS
METHODS
TABLE 1 - Consumption of alcoholic beverages by HBV-infected patients.
     Sex 
                                                                               male          female 
Quantity of alcohol consumed per day in grams n % n % p
Absent 110 34.4 185 88.5 <0.001
Less than 20 79 24.8 13 6.3 <0.001
20 to 40 43 13.4 4 1.9 <0.001
More than 40 63 19.6 3 1.4 <0.001
Unknown  25.0 7.8 4.0 1.9
Total 320 100.0 209 100.0
The objective of the present study was to determine the clinical, 
demographic and epidemiological characteristics of chronically HBV-
infected patients followed in Ribeirão Preto, a city in the interior of 
the State of São Paulo.
This work was conducted as a descriptive epidemiological 
study. The medical records of HBV-infected patients attended 
at the Hepatitis B Outpatient Clinic of the University Hospital, 
Faculty of Medicine of Ribeirão Preto, University of São Paulo (HC-
FMRP-USP) from June 2004 to June 2008 were reviewed. Of these, 
529 HBV-infected patients were included in the study. Inclusion 
criteria were HBsAg positive patients at diagnosis, with anti-HCV 
and anti-HIV negative markers.
Data regarding patient identification, referral source, alcohol 
consumption and risk factors related to HBV transmission were 
collected. Abusive alcohol consumption was considered to be present 
when more than 20g a day were consumed for more than 10 years.
Anti-HBc IgG-positive antibodies in the mother and/or at least 
one sibling were considered to indicate possible vertical/intrafamilial 
transmission of HBV. Risky sexual contact was defined as more 
than three sex partners per year, a report of a sexually transmissible 
disease, sexual contact with an individual known to be infected with 
HBV, or in the case of men who had sex with men. Percutaneous 
exposure to potentially contaminated material was considered to 
have occurred when the patient reported the execution of tattoos, 
piercings or acupuncture.
The following determinations were performed: measurement 
of alanine aminotransferase (ALT), quantitative DNA values of B 
virus (HBV DNA), presence of HBsAg and HBeAg antigens and of 
anti-HBcAg IgG and IgM, anti-HBsAg and anti-HBeAg antibodies 
in serum and, when available, a liver biopsy. On the basis of these 
data, the patients were classified into different evolutive stages of the 
disease: acute hepatitis, immune tolerance phase, chronic HBeAg-
positive hepatitis, inactive HBV or HBeAg-negative chronic hepatitis, 
according to the criteria of the American Association for the Study 
of Liver Diseases (AASLD)18. Cirrhosis was diagnosed according 
to the histopathological findings of the liver biopsy. When a biopsy 
was not available, the diagnosis was made on the basis of clinical 
(ascites, hepatic encephalopathy), biochemical (prothrombin time, 
serum bilirubin and albumin), ultrasonographic (nodules in the 
liver parenchyma), and endoscopic (signs of portal hypertension) 
parameters. HCC was diagnosed by imaging exams (ultrasonography 
+ computed tomography and/or magnetic resonance), by the 
determination of serum alpha-fetoprotein and, when available, by 
histopathological analysis of the tumor.
The information collected was stored in a data bank using the 
Excel 2003 software (Microsoft Office). Data are expressed by means 
of descriptive statistical analysis or were analyzed by the Student t 
test, Chi square test and Fisher exact test using the SPSS version 17.0 
software. The level of significance was set at p<0.05 in all analyses.
Ethical considerations
The study was approved by the Research Ethics Committee of 
the Clinics Hospital of the Faculty of Medicine of Ribeirão Preto, 
University of São Paulo, Ribeirão Preto (HC-FMRP-USP) (protocol 
n 14339/2006).
Of the 529 patients included in the study, 320 (60.5%) were 
males. Age at the beginning of follow-up ranged from 12 to 79 years-
old, with a mean of 38 years-old. The age of 84% of the patients 
ranged from 20 to 59 years-old. Mean age was similar for men 
(38.0 years-old) and women (37.8 years-old) (p = 0.85).
Of the total number of patients included in the study, 
208 (39.3%) were referred by clinicians, 181 (34.2%) were referred 
by the Ribeirão Preto Blood Center and 103 (19.5%) were included 
after family screening. Information regarding the source of referral 
was not available in 37 (7%) medical records.
Two hundred and ninety-six (56%) patients reported that they 
had not consumed alcohol in any phase of life. The absence of alcohol 
consumption was more common among women than among men; 
i.e., 88.5% and 34.4%, respectively (p < 0.001). Data regarding the 
amount of alcohol consumed by the men and women included in 
the study are listed in Table 1.
Eight patients (1.5%) presented symptomatic acute hepatitis on 
the occasion of the first visit. One of them developed acute hepatic 
insufficiency and died, another developed chronification of the 
infection and six progressed to spontaneous cure. The remaining 
521 (98.5%) patients included in the study presented chronic HBV 
infection since the beginning of follow-up. 
Of the 521 patients with chronic HBV infection, 440 (84.5%) 
had the HBeAg-negative and anti-HBeAg-positive serological 
pattern. Of these, 238 (54.1%) presented active chronic hepatitis 
and 202 (45.9%) were inactive HBV carriers. Eighty-one (15.5%) 
individuals had the HBeAg-positive and anti-HBeAg-negative 
serological pattern. Fifty-nine (72.8%) of the latter presented active 
chronic hepatitis and the remaining 22 (27.2%) were in the immune 
tolerance phase. Of the 521 patients with chronic HBV infection, 
297 (57%) presented active chronic hepatitis.
Analysis of the HBeAg and anti-HBeAg serological pattern at 
the beginning of patient follow-up revealed a tendency toward an 
increased number of HBeAg-negative and anti-HBeAg-positive 
individuals over time; i.e., between January 1992 and December 
2007 (Figure 1). Data for 2008 were excluded from this analysis, 
because the collection did not include the second half of the year 
in question.
The clinical, demographic and epidemiological characteristics 
of patients with chronic HBV infection with HBeAg-positive and 
HBeAg-negative patterns (age, sex, risk factor, presence of cirrhosis 
and HCC) are presented in Table 2. 
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TABLE 2 - Clinical, demographic and epidemiological characteristics of 
patients with chronic hepatitis B infection according to the serological pattern 
of the HBe antigen.
 HBeAg positive HBeAg negative 
 n = 81 n = 440 
Mean age (years) 36.7 38.4 p
 n % n % 0.40
Male sex 59 72.8 256 64 0.02
Possible mode of transmission     
vertical/intrafamilial 24 29.3 190 43.2 0.02
sexual 27 33.0 94 21.4 0.02
transfusion of blood products 13 16.0 48 10.9 0.19
percutaneous 8 9.8 10 2.3 <0.001
risky injections - - 12 2.7 0.23
hemodialysis 2 2.4 7 1.6 0.64
health professionals 1 1.2 16 3.6 0.49
unidentified 21 26.5 138 31.4 0.95
more than one factor 15 18.5 66 15.0 0.42
Presence of cirrhosis 20 24.4 45 10.2 <0.001
Presence of  HCC* 3 3.6 13 2.9 0.72
*HCC: hepatocellular carcinoma
TABLE 3 - Clinical, demographic and epidemiological characteristics of 
patients with active chronic hepatitis B, according to the serological pattern 
of the HBe antigen.
 HBeAg positive HBeAg negative 
 n = 59 n = 238 
Mean age (years) 37.4 38.8 p
 n % n % 0.48
Male sex 44 74.5 146 61.1 0.06
Possible mode of transmission     
vertical/intrafamilial 19 32.2 99 41.6 0.18
sexual 19 32.2 48 20.1 0.04
transfusion of blood products 12 20.3 32 13.4 0.18
percutaneous 6 10.1 5 2.1 0.01
risky injections - - 6 2.5 0.60
hemodialysis 1 1.7 7 2.9 1.00
health professionals 1 1.7 7 2.9 1.00
unidentified 12 20.3 74 31.1 0.10
more than one factor 12 20.3 31 13.0 0.15
Alcohol intake (> 20g/day) 20 33.9 51 21.4 0.04
Presence of cirrhosis 20 33.9 39 16.3 <0.001
Presence of  HCC* 3 13.6 9 3.7 0.71
*HCC: hepatocellular carcinoma
FIGURE 1 - Distribution of the number of new cases of patients with hepatitis B attended at HC-FMRP-
USP between 1992 and 2007, according to the serological pattern of the HBe antigen.
Table 3 lists the clinical, demographic and epidemiological data 
of HBeAg-positive and HBeAg-negative patients with active chronic 
hepatitis. Patients in the immune tolerance phase and patients with 
inactive HBV infection were not included in this table. Data were 
analyzed statistically in a univariate manner.
Of the total of 521 patients with chronic HBV infection, 
65 (12.5%) received a diagnosis of cirrhosis during the study period. 
The mean age of these cirrhotic patients was greater than that of 
the group of non-cirrhotic patients (48.7 versus 36.5 years-old) 
(p < 0.001). Seventy-eight percent were men (51/65), demonstrating 
an association between male sex and this form of hepatic disease 
(p = 0.001). Information concerning alcohol consumption was 
available for 59 cirrhotic patients. In the male group, 26 (54.1%) out 
of 48 cirrhotic patients consumed more than 20g of alcohol a day, and 
the association was significant (p = 0.004). None of the seven women 
who consumed alcohol had cirrhosis and therefore it was not possible 
to determine associations between alcohol abuse and cirrhosis in this 
16
group. Among HBeAg-negative patients with chronic hepatitis who 
abused alcoholic beverages, 31.4% were cirrhotic (16/51), and the 
association between alcohol and cirrhosis was significant in this group 
(p = 0.001). Among HBeAg-positive patients with chronic hepatitis 
who abused alcoholic beverages, 45% (9/20) were cirrhotic, although 
in this group no significant association was observed between alcohol 
abuse and cirrhosis (p = 0.197).
Sixteen patients (3%) had HCC, 14 of them with underlying 
cirrhosis and two without cirrhosis. The mean age of patients with HCC 
exceeded that of patients without HCC (50.8 versus 37.5 years-old) 
(p = 0.001). No association was detected between the presence of 
HCC and alcohol consumption (p = 1.000). 
During the study period, six patients were submitted to a liver 
transplant at HC-FMRP-USP: one due to acute hepatic insufficiency, 
two due to HCC in a cirrhotic liver and three with decompensation 
of cirrhosis. Three transplanted patients died. Of the total number 
of individual studied, 15 died of causes related to HBV infection 
during the study period.
DISCUSSION
The Clinics Hospital of the Faculty of Medicine of Ribeirão Preto, 
University of São Paulo, Ribeirão Preto (HC-FMRP-USP) belongs to 
the XIII Regional Health Department of the Health Secretariat of the 
State of São Paulo and is the principal tertiary reference center in the 
Ribeirão Preto region, which includes 26 municipalities and approximately 
1,130,000 inhabitants19. The hepatitis B outpatients clinics of this hospital 
treats patients with an indication of drug treatment and more severe 
cases of hepatic disease caused by HBV. This clinic also represents a 
reference center for cases detected during the donation of blood products 
at the Ribeirão Preto Blood Center. As observed in the current study, 
most (98.5%) of the care provided by this service involves patients 
with chronic HBV infection. Cases of symptomatic acute infection are 
believed to be retained in the primary and secondary health networks. 
Analysis of cases of chronic infection revealed a predominance 
of individuals with the HBeAg-negative/anti-HBeAg-positive 
serological pattern, with a tendency toward an increase in new 
HBeAg-negative cases in relation to new HBeAg-positive cases. 
Studies conducted in France in 1994 and 2003 demonstrated that 
cases of HBeAg-negative chronic hepatitis also became the most 
frequent in this region of the European continent over the last 
decade20,21. Cases of HBeAg-negative hepatitis B also predominate in 
Greece, with the proportion of Greek patients showing an HBeAg-
negative and anti-HBeAg- positive pattern reaching 93.3%22. Studies 
conducted in Italy, Portugal and Spain have also demonstrated high 
rates of this serological pattern of chronic HBV23-25. Studies conducted 
in Brazil have shown differences in the prevalence of HBeAg-negative 
chronic hepatitis. In northeastern Brazil, in the State of Bahia, Ribeiro 
et al16 studied 76 individuals with chronic HBV infection and did 
not identify any patients with HBeAg-negative chronic hepatitis. 
In contrast, in a study involving 139 HBV-infected patients in the 
City of Campinas, in the southeast region of the State of São Paulo, 
Tonetto et al17 detected high proportions (70%) of HBeAg-negative 
individuals. Similar to that observed in the Campinas study, HBeAg-
negative cases predominated in the present study, a fact possibly 
reflecting greater circulation of HBV originating from the European 
continent, particularly the Mediterranean region. In contrast, 
regarding northeastern Brazil, the data suggest that there is a greater 
prevalence of HBV originating from the African continent16,17,26. 
A previous study conducted in Ribeirão Preto between 1999 
and 2002 showed that, of the total number of HBV-infected patients 
studied, 36% presented precore and core-promoter mutations: HBV 
variants that affect the production of the HBe antigen27. In that study, 
although the number of patients was small (n = 50), it was possible 
to observe that no difference in age was verified between the groups 
of HBeAg-positive and HBeAg-negative patients27. Similarly, in 
the present study, no difference occurred between the groups of 
HBeAg-positive and HBeAg-negative patients. These data disagree 
with results reported in other studies3,17,20,22. Since this is a later 
stage of infection, greater values for age were expected for the group 
of HBeAg-negative patients3. The explanation for these data is not 
clear, but we suggest that transmission of previously mutant HBV 
forms, defective for HBeAg synthesis, may have occurred among 
younger individuals. This hypothesis is supported by the increase in 
the proportion of HBeAg-negative cases over the last 15 years, a fact 
that may reflect greater circulation of mutant viruses in our region. 
However, the fact that HBeAg-negative patients submitted to antiviral 
treatment were not excluded from this study should be taken into 
consideration, with the possibility of bias in the data obtained due to 
the presence of these patients in whom seroconversion of the HBe 
antigen was induced by medications.
Regarding the possible mode of transmission, high proportions of 
sexual risk were verified among the patients with the HBeAg-positive 
serological pattern, with a predominance of male patients in this 
group. On the other hand, a high proportion of patients in general 
with the possibility of vertical/intrafamilial transmission of HBV were 
also verified, in particular among patients with the HBeAg-negative 
forms (43.2%). Studies conducted in Brazil have demonstrated high 
frequencies of this type of transmission among people living in the 
same household13-15. In a study conducted in Acre, a region of high 
endemicity for HBV infection in the northern Brazil, Lobato et al15 
detected a high frequency of HBV transmission in the domestic 
environment among the relatives of HBsAg-positive pregnant 
women. Motta-Castro et al14 also demonstrated a high frequency 
of HBV transmission in the family environment, especially among 
children, in an Afrodescendant community with a high prevalence 
of HBV infection in the central-western region of Brazil. This last 
study and others have suggested that dissemination of the virus in 
the family environment may be more important among individuals of 
lower socioeconomic level and living in poor hygiene conditions13,14. 
Although the HBeAg-negative serological pattern and the vertical/
intrafamilial form of transmission are known to be more frequent 
in regions of greater endemicity of infection, studies conducted in 
Ribeirão Preto on different population groups have suggested a low 
prevalence of HBV infection9,10,28. However, since in general the 
patients treated at HC-FMRP-USP are of low socioeconomic level, 
this result may support the hypothesis raised by Motta-Castro14.
In the study model used here, it was not possible to estimate the 
rates of progression to cirrhosis and to HCC, but it was possible to 
observe that the proportion of individuals with these complications 
was similar to that detected in other studies3,20,22. Regarding the 
possible factors related to progression to cirrhosis, this work was 
in agreement with published data regarding the predominance of 
these forms of hepatic disease in older individuals1-3. Higher rates of 
cirrhosis were observed in the HBeAg-positive group with chronic 
hepatitis. Although some studies conducted in European countries 
have detected greater proportions of cirrhotic individuals in the group 
of HBeAg-negative patients, there is no consensus regarding the 
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higher risk of vertical/intrafamilial transmission. Abusive alcohol 
consumption was associated with male subjects and with cirrhosis 
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This work was financially supported by the Fundação de 
Amparo à Pesquisa do Estado de São Paulo (FAPESP).
1. Lok ASF, McMahon BJ. Chronic Hepatitis B: Update 2009. Hepatology 
2009; 50:661-697.
2. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 
2006; 101(suppl):1-6.
3. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: 
special emphasis on disease progression and prognostic factors. J Hepatol 2008; 
48:335-352.
4. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. 
Clin Liver Dis 2005; 9:191-211. 
5. Silveira TR, Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, et al. Hepatitis B 
seroprevalence in Latin America. Rev Panam Salud Publica 1998; 6: 378-383.
6. Focaccia R, Conceição OJ, Sette Jr H, Sabino E, Bassit L, Nitrini DR, et al. Estimated 
prevalence of viral hepatitis in the general population of the municipality of São 
Paulo, measured by a serologic survey of a stratified, randomized and residence-
based population. Braz J Infect Dis 1998; 2:269-284.
7. Toledo Jr AC, Greco DB, Felga M, Barreira D, Gadelha M de F, Speranza FA. 
Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002. 
A cross-sectional study. Braz J Infect Dis 2005; 9:374-383.
8. Pereira LMMB, Martelli CMT, Merchán-Hamann E, Montarroyos UR, Braga MC, 
Lima MLC, et al. Population-based multicentric survey of hepatitis B infection 
and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 
2009; 81:240-247.
9. Miranda LVG, Passos ADC, Figueiredo JFC, Gaspar AMC, Yoshida CFT. 
Serological markers of hepatitis B in people submitted to blood testing in health 
care clinics. Rev Saúde Publica 2000; 34:286-291.
10. Valente VB, Covas DT, Passos ADC. Hepatitis B and C serologic markers in 
blood donors of the Ribeirão Preto Blood Center. Rev Soc Bras Med Trop 2005; 
38:488-492.
11. Paraná R, Vitvitski L, Pereira JE. Hepatotropic Viruses in the Brazilian Amazon: 
A Health Threat. Braz J Infect Dis 2008;12:253-256.
12. Aquino JA, Pegado KA, Barros LP, Machado LFA. Soroprevalência de infecções 
por vírus da hepatite B e vírus da hepatite C em indivíduos do estado do Pará. 
Rev Soc Bras Med Trop 2008; 41:334-337.
13. Passos ADC, Gomes UA, Figueiredo JFC, Nascimento MMP, Oliveira JM, 
Gaspar AMC, et al. Influence of migration on prevalence of serological hepatitis 
B markers in a rural community. Analysis of a prevalence by birth-place. 
Rev Saude Publica 1993; 27:30-35.
14. Motta-Castro ARC, Yoshida CFT, Lemos ERS, Oliveira JM, Cunha RV, Lewis-
Ximenez LL, et al. Seroprevalence of Hepatitis B Virus Infection among an 
Afrodescendant Community in Brazil. Mem Inst Oswaldo Cruz 2003; 98:13-17.
15. Lobato C, Tavares-Neto J, Rios-Leite M, Trepo C, Vitvitski L, Parvaz P, et al. 
Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: 
epidemiologic and biomolecular study. J Gastroenterol Hepatol 2006; 21:863-868.
16. Ribeiro NRC, Campos GS, Ângelo ALD, Braga EL, Santana N, Gomes MMS, 
et al. Distribution of hepatitis B virus genotypes among patients with chronic 
infection. Liver Int 2006; 26:636-642.
17. Tonetto PA, Gonçales NSL, Fais VC, Vigani AG, Gonçales ESL, Feltrin A, et al. 
Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-
infected patients in the southeast of Brazil. BMC Infect Dis 2009; 9:149-156.
18. Lok ASF, McMahon BJ. Chronic Hepatitis B: Update 2007. Hepatology 
2007; 45:507-539.
19. Secretaria de Estado da Saúde de São Paulo [Internet]. [cited 2010 Apr 10]. 
Available from:  http://portal.saude.sp.gov.br/content/geral_estrutura_
regionais_de_saude.mmp/. 
20. Zarski JP, Marcellin P, Cohard M, Lutz JM, Bouché C, Raïs A, et al. Comparison 
of anti-HBe positive and HBe-antigen positive chronic hepatitis B in France. 
J Hepatol 1994; 20:636-640. 
21. Zarski JP, Marcellin P, Leroy V, Trepo C, Samuel D, Ganne-Carrie N, et al. 
Characteristics of patients with chronic hepatitis B in France: predominant 
frequency of HBe antigen negative cases. J Hepatol 2006; 45:355-360.
22. Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis 
D, Vasiliadis T, et al. Epidemiology, course and disease burden of chronic hepatitis 
B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek 
study. J Viral Hepat 2009; 16:195-202.
23. Torre F, Basso M, Giannini EG, Feasi M, Boni S, Grasso A, et al. Clinical and 
virological survey of patients with hepatitis b surface antigen in an italian region: 
clinical considerations and disease burden. J Med Virol 2009; 81:1882-1886.
24. Mota A, Guedes F, Areias J, Pinho L, Cardoso MF. Epidemiological study 
of genotypes of hepatitis B virus in Northern Portugal. J Med Virol 2009; 
81:1170-1176.
25. Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, et al. 
Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients 
with acute and chronic HBV infection. J Viral Hepat 2006; 13:343-350.
26. Mello FCA, Souto FJD, Nabuco LC, Villela-Nogueira CA, Coelho HSM, 
Franz HCF, et al. Hepatitis B virus genotypes circulating in Brazil: molecular 
characterization of genotype F isolates. BMC Microbiol 2007; 7:103-111.
27. Rezende REF, Fonseca BAL, Ramalho LNZ, Zucoloto S, Pinho JRR,  Bertolini DA, 
et al. The precore mutation is associated with severity of liver damage in Brazilian 
patients with chronic hepatitis B. J Clin Virol 2005; 32:53-59.
28. Passos ADC, Figueiredo JFC, Martinelli ALC, Villanova MG, Nascimento MP, 
Gaspar AMC, et al. Hepatitis B among female sex workers in Ribeirão Preto - 
São Paulo, Brazil. Rev Bras Epidemiol 2007; 10:517-524.
29. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk 
based on the level of circulating hepatitis B viral load. Gastroenterology 
2006; 130:678-686.
30. Mota A, Guedes F, Areias J, Pinho L, Cardoso MF. Alcohol consumption among 
patients with hepatitis B infection in northern Portugal considering gender and 
hepatitis B virus genotype differences. Alcohol 2010; 44:149-156.
Rev Soc Bras Med Trop 44(1):13-17, jan-fev, 2011
